ERIN NESTER: Open Payments
NPI 1235606641 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 34 payments from 12 companies in 2025. Trend: 2023 $468 · 2024 $417 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $115 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Tris Pharma Inc | 3 | $51 |
| Indivior Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $40 |
| Alkermes, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: REXULTI, CAPLYTA, Auvelity, COBENFY, Dyanavel XR, SUBLOCADE, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across IN — which companies pay providers there.
